Skip to main content
logo
Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Silo Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
25441114
Market Cap Growth
-69.77%13.46%-8.51%-58.64%-24.99%-61.09%
Enterprise Value
-3-1-4-4-23
Last Close Price
1.185.1013.3521.6050.40106.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----5.63
PS Ratio
34.6662.8055.3560.50146.27197.30
PB Ratio
0.270.720.790.711.021.55
P/TBV Ratio
0.400.740.830.711.021.55

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----41.80

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.07-1.09-1.41-1.24-1.10-1.13
Net Debt / EBITDA Ratio
1.181.611.51---
Asset Turnover
0.010.010.010.010.010.01
Quick Ratio
4.9110.554.289.8826.0620.93
Current Ratio
5.3611.364.299.9026.5221.23
Return on Equity (ROE)
-91.23%-74.56%-78.37%-43.97%-40.28%80.38%
Return on Assets (ROA)
-44.25%-35.63%-38.80%-24.86%-20.60%-30.34%
Return on Capital Employed (ROCE)
-91.30%-61.50%-81.80%-55.30%-32.50%-28.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-238.61%-93.36%-110.06%-84.83%-37.06%27.76%
Buyback Yield / Dilution
-170.50%-127.75%-19.50%-34.83%-19.07%-45.44%
SEC Filings: 10-K · 10-Q